EQUILLIUM
Equillium Inc is a biotechnology company that develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with an unmet medical need. Its primary product candidate is EQ001, which is a clinical-stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus, and multiple sclerosis.
EQUILLIUM
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2017-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.equilliumbio.com
Total Employee:
11+
Status:
Active
Contact:
858 412 5302
Total Funding:
85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-09-06 | Metacrine | Metacrine acquired by Equillium | N/A |
| 2022-02-16 | Bioniz Therapeutics | Bioniz Therapeutics acquired by Equillium | N/A |
Investors List
Decheng Capital
Decheng Capital investment in Post-IPO Equity - Equillium
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Equillium
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Equillium
Official Site Inspections
http://www.equilliumbio.com Semrush global rank: 2.05 M Semrush visits lastest month: 10.18 K
Unable to get host informations!!!
More informations about "Equillium"
Equillium - Our Company
Our Partners As Equillium was founded, the company acquired rights for developing and commercializing itolizumab in the U.S., Canada, Australia and New Zealand through an exclusive collaboration and license agreement with …See details»
Equillium - Crunchbase Company Profile & Funding
Organization. Equillium . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number …See details»
Equillium Maintains Rights to Itolizumab Following Ono Partnership
Oct 31, 2024 Ono Pharmaceutical makes strategic business decision to allow itolizumab option to expire Equillium evaluating accelerating completion of Phase 3 EQUATOR study in aGVHD …See details»
Equillium, Inc. - LinkedIn
Equillium, Inc. | 5,129 followers on LinkedIn. Resetting Balance, Restoring Health | Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to pioneer ...See details»
Equillium Bio - Products, Competitors, Financials, Employees ...
Dec 10, 2018 Equillium Bio (NASDAQ: EQ) is a biotechnology company. Use the CB Insights Platform to explore Equillium Bio's full profile.See details»
Equillium - Home
When life hangs in the balance. Equillium is actively recruiting individuals to participate in clinical trials for alopecia areata, celiac disease, acute graft-versus-host disease (aGVHD) and lupus nephritis.See details»
Equillium Company Profile - Craft
Oct 29, 2024 Equillium is a biotechnology company developing products for autoimmune and inflammatory disorders. It offers Itolizumab, amonoclonal antibody that targets the CD6 …See details»
Equillium - VentureRadar
"Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory …See details»
Equillium - Investor Relations
Nov 13, 2024 For more information, visit www.equilliumbio.com. Featured Presentation. View All Presentations. Upcoming Events. View All Events. Latest News. View All News. Contact Us. …See details»
Bruce Steel - CEO & Director at Equillium - The Org
Bruce is a co-founder, Director, and President and Chief Executive Officer of Equillium. He is also the founder and Managing Director of BioMed Ventures, the strategic investment arm of …See details»
Equillium, Inc. | Insights
Oct 3, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Equillium - workinbiotech.com
Equillium is using advances in immunobiology to create therapeutics to treat autoimmune diseases. A healthy immune system needs to be correctly balanced to ensure it is activated …See details»
Ono and Equillium Announce Exclusive Option and Asset Purchase ...
Dec 6, 2022 Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO, Gyo Sagara; “Ono”) today announced that it has entered into an exclusive option and asset purchase …See details»
Equillium, Inc. Email Format | equilliumbio.com Emails
The most common Equillium, Inc. email format is [first_initial][last] (ex. [email protected]), which is being used by 100.0% of Equillium, Inc. work email addresses. Other common …See details»
Equillium - Contact Us
Equillium, Inc. (Headquarters) 2223 Avenida De La Playa, Suite 105 La Jolla, California 92037 858-240-1200See details»
Equillium (Nasdaq:EQ) - Stock Price, News & Analysis - Simply …
Nov 27, 2024 www.equilliumbio.com: Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno …See details»
Equillium Announces Positive Topline Results from the
Jun 11, 2021 Equillium has received fast track designation from the FDA for the treatment of itolizumab in patients with aGVHD and orphan drug designations from the FDA for both the …See details»
Equillium - Careers
Opportunities. Equillium is seeking individuals who want to make a difference in patients’ lives! If you are a recruiting agency, we appreciate your interest in partnering with us.See details»
EquiLife
Equilibrium Nutrition is now Equilife! Dr. Stephen Cabral's online Natural Health store offering you the highest quality nutritional supplements and Functional Medicine lab testing in the world. …See details»